13F HOLDINGS REPORT
Sio Capital Management, LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001214659-23-002122
Total Value
$270.4M
Positions
47
Other Managers
0
Confidential Omitted
No
Holdings (47)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 574,200 | $63.2M | 23.36% |
| 2 | MEDICUS SCIENCES ACQUISITION | G5960S108 | 2,323,000 | $23.4M | 8.65% |
| 3 | BICYCLE THERAPEUTICS PLC | BCYC | 683,425 | $20.2M | 7.48% |
| 4 | CIGNA CORP | 125523100 | 52,611 | $17.4M | 6.45% |
| 5 | ORGANON & CO | OGN | 587,836 | $16.4M | 6.07% |
| 6 | UNITED THERAPEUTICS CORP | UTHR | 54,959 | $15.3M | 5.65% |
| 7 | QUEST DIAGNOSTICS INC | DGX | 92,000 | $14.4M | 5.32% |
| 8 | AMERISOURCEBERGEN CORP | COR | 84,399 | $14.0M | 5.17% |
| 9 | MEDTRONIC PLC | MDT | 128,000 | $9.9M | 3.68% |
| 10 | STAAR SURGICAL CO | STAA | 157,129 | $7.6M | 2.82% |
| 11 | ICON PLC | ICLR | 33,983 | $6.6M | 2.44% |
| 12 | INOGEN INC | INGN | 286,692 | $5.7M | 2.09% |
| 13 | AVANTOR INC | AVTR | 250,000 | $5.3M | 1.95% |
| 14 | HESKA CORP | 42805E306 | 84,309 | $5.2M | 1.94% |
| 15 | PROTAGONIST THERAPEUTICS INC | PTGX | 434,635 | $4.7M | 1.75% |
| 16 | NOVAVAX INC | NVAX | 340,000 | $3.5M | 1.29% |
| 17 | CYMABAY THERAPEUTICS INC | 23257D103 | 555,610 | $3.5M | 1.29% |
| 18 | PHARVARIS NV | PHVS | 285,000 | $3.2M | 1.19% |
| 19 | MERRIMACK PHARMACEUTICALS INC | 590328209 | 250,000 | $2.9M | 1.06% |
| 20 | REATA PHARMACEUTICALS INC | 75615P103 | 67,000 | $2.5M | 0.94% |
| 21 | HEALTH SCIENCES ACQUISITIONS CORP 2 | G4411D109 | 250,000 | $2.5M | 0.92% |
| 22 | EUCRATES BIOMEDICAL ACQUISITION CORP. | G3141W114 | 248,674 | $2.5M | 0.92% |
| 23 | CTI BIOPHARMA CORP | 12648L601 | 330,000 | $2.0M | 0.73% |
| 24 | IVERIC BIO INC | 46583P102 | 86,400 | $1.8M | 0.68% |
| 25 | X4 PHARMACEUTICALS INC | XFOR | 1,825,963 | $1.8M | 0.67% |
| 26 | MODULAR MEDICAL INC | MODD | 689,352 | $1.4M | 0.51% |
| 27 | MERUS NV | N5749R100 | 87,953 | $1.4M | 0.50% |
| 28 | AEGLEA BIO THERAPEUTICS INC | 00773J103 | 3,004,959 | $1.4M | 0.50% |
| 29 | SAVARA INC | SVRA | 866,448 | $1.3M | 0.50% |
| 30 | IDEAYA BIOSCIENCES INC | IDYA | 70,000 | $1.3M | 0.47% |
| 31 | TYRA BIOSCIENCES INC | TYRA | 152,159 | $1.2M | 0.43% |
| 32 | MOLECULIN BIOTECH INC | MBRX | 1,036,853 | $1.1M | 0.41% |
| 33 | VANDA PHARMACEUTICALS INC | VNDA | 136,325 | $1.0M | 0.37% |
| 34 | RELMADA THERAPEUTICS INC | RLMD | 235,600 | $822,244 | 0.30% |
| 35 | RELMADA THERAPEUTICS INC | RLMD | 235,500 | $821,895 | 0.30% |
| 36 | FUSION PHARMACEUTICALS INC | 36118A100 | 260,448 | $820,411 | 0.30% |
| 37 | CONNECT BIOPHARMA HOLDINGS LTD | CNTB | 597,678 | $518,665 | 0.19% |
| 38 | SIENTRA INC | 82621J105 | 2,550,000 | $517,395 | 0.19% |
| 39 | ASLAN PHARMACEUTICALS LTD | 04522R101 | 1,270,758 | $457,473 | 0.17% |
| 40 | ELEVATION ONCOLOGY INC | 28623U101 | 359,731 | $341,744 | 0.13% |
| 41 | NEXTCURE INC | NXTC | 130,000 | $183,300 | 0.07% |
| 42 | CAREMAX INC | 14171W103 | 30,741 | $112,205 | 0.04% |
| 43 | VINCERX PHARMA INC | VNCE | 102,049 | $104,090 | 0.04% |
| 44 | NYXOAH SA | NYXH | 16,110 | $80,389 | 0.03% |
| 45 | HUMACYTE INC | HUMAW | 49,998 | $20,314 | 0.01% |
| 46 | NEOLEUKIN THERAPEUTICS INC | 64049K104 | 38,312 | $19,501 | 0.01% |
| 47 | CAREMAX INC | 14171W103 | 12,808 | $6,692 | 0.00% |